glp 1 agonist drugs GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP-1 Receptor Agonists and Other

Arbutin , specifically alpha arbutin, is considered to be an ideal skin lightening agent, says Dr

F., Lobine, D., Akram, M., Riaz, M., Capanoglu, E., Sharopov, F., Martins, N., Cho, W

TB-500 (Thymosin 4 fragment): Explored for interactions with G-actin that influence cell motility, cytoskeletal organization, and wound-healing dynamics

Acute Critical Illness Increased mortality in patients with acute critical illness due to complications following open heart surgery, abdominal surgery or multiple accidental trauma, or those with acute respiratory failure has been reported after treatment with pharmacologic amounts of growth hormone

Oxidative Stress as the Link to Vascular Dysfunction Disruption of glutathione homeostasis has immediate implications for the vascular endothelium, where oxidative stress directly undermines nitric oxide (NO) signaling and vascular integrity

However, phase II clinical trials were conducted to investigate ipamorelin for post-operative ileus treatment but the trials were discontinued due to its limited efficacy